Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
about
Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatologyMass spectrometry-based proteomics for pre-eclampsia and preterm birthIdentification of novel translational urinary biomarkers for acetaminophen-induced acute liver injury using proteomic profiling in miceSeminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced diseaseInformed baseline subtraction of proteomic mass spectrometry data aided by a novel sliding window algorithm.A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry.Approaching clinical proteomics: current state and future fields of application in fluid proteomics.Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting.Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.Development of oleic acid-functionalized magnetite nanoparticles as hydrophobic probes for concentrating peptides with MALDI-TOF-MS analysis.Analysis of the urinary peptidome associated with Helicobacter pylori infection.Urinary protein profiling in hyperactive delirium and non-delirium cardiac surgery ICU patients.Serum peptidome profiling in patients with gastric cancer.Detection of Leishmania donovani infection using magnetic beads-based serum peptide profiling by MALDI-TOF MS in mice model.Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).Evaluation of inter-day and inter-individual variability of tear peptide/protein profiles by MALDI-TOF MS analyses.Detection of ricin intoxication in mice using serum peptide profiling by MALDI-TOF/MSNon-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples.Freezing adversely affects measurement of vascular endothelial growth factor levels in human aqueous samples.Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling.Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomes.Proteomic profiling in incubation medium of mouse, rat and human precision-cut liver slices for biomarker detection regarding acute drug-induced liver injury.Biospecimen Reporting for Improved Study Quality.Biospecimen reporting for improved study quality (BRISQ)An analysis of the impact of pre-analytical factors on the urine proteome: Sample processing time, temperature, and proteolysis.Proteomic profiling of occupational medicamentosa-like dermatitis induced by trichloroethylene in serum based on MALDI-TOF MS.Reproducibility in urine peptidome profiling using MALDI-TOF.Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.Systems biology of kidney diseases.Magnetic Bead-Based Serum Peptidome Profiling in Patients with Gestational Diabetes Mellitus.Comparative peptidome analyses of the profiles of the peptides ranging from 1-10 KD in CSF samples pooled from probable sporadic CJD and non-CJD patients.Proteomic study of benign and malignant pleural effusion.Detection of murine toxoplasmosis using magnetic bead-based serum peptide profiling by MALDI-TOF MS.An Optimized Informatics Pipeline for Mass Spectrometry-Based Peptidomics.Biomarker discovery in mass spectrometry-based urinary proteomics.
P2860
Q26829452-00E3F647-6C35-4136-886E-F8D14CD0EC20Q28083761-0B5CE80A-867C-4A20-878E-399C864E1101Q28485164-BAC68A3C-8174-45DD-9F66-DDFB7C9A0971Q28534235-42158D88-E705-4C0E-AE14-DAE929A8B68DQ31149213-4C81EA1D-9806-424E-92CF-FDB212C1DA76Q33384944-99C2D487-F480-4C19-8045-68A68F0C287CQ33467523-AFDCA19F-48F0-42BB-B51E-5B111E6B6636Q33545673-5A8DCE8B-CD9C-4E6C-9684-563F722BF779Q33546553-6ADD4F56-7FD9-405F-9F49-F0CDEF496F05Q33579375-B4052B23-4D09-4AF9-B311-1A535873398EQ33778668-534EEEEB-A3AD-4289-82C4-67C68F2F17C5Q33781011-72EB0661-D7A0-4120-972D-A7AE85F25D99Q33805155-1AAEC44C-E502-48A7-880D-88350282D5E5Q33829666-774F96FB-ADC1-4B5F-8097-9101054AB0C1Q33852628-61A81788-CFC1-4ADE-BAC6-60A07C4D73CEQ33955495-123396F9-BB2C-47A2-8FB7-88181BA1A6E0Q33995769-46EE9575-6D98-4A46-B55E-4512B60C5874Q34187912-6C567946-8959-45DD-828C-61C859BB8C7BQ34281288-C85E41B3-7852-4846-9042-4034F08ED450Q34318147-80EB1408-2DCE-4747-83E3-2AE3C38BEF0FQ34497856-63394626-9F4D-43B3-B1F3-5A43BB5F52BDQ34546734-2923708B-8B9F-4196-BBDB-C8900E851EAAQ34548699-24F198E3-ED00-4380-BC8C-CDC7E384A90DQ34653849-204D0374-D1D4-49D0-ACD6-A40FC73A1666Q34664488-E8396BA0-F9B4-4DF5-82C9-292158FC102FQ34855337-BE90CF9D-31C4-4D11-896B-6CA87114A702Q34987732-CC049063-6734-48A3-A063-4F05F57345FFQ35125775-EA4DA88A-5677-4B6C-A52C-A0991275A2CAQ35203154-C8203260-76BE-4E11-AFF8-19E4D577627EQ35423674-D7D77633-732F-4C35-9218-C62FB58F4158Q35491175-D09987D8-0811-4B70-9FDF-10D4150D5689Q35530393-3D900885-68BB-42C0-9C3F-E62EB826F2EBQ35560299-A7D3AC75-8CE4-4E61-BF34-D893D2E87E19Q35619034-F3C9C63C-81CB-422B-9267-2C13E41AF031Q35668225-0EE31020-C7AD-4CB0-87FA-2562BD9D4903Q35918933-EF27DF22-17BF-4C50-A9A6-7B9F8AF55B1BQ35946652-2BD997D3-BE20-4423-8A15-58D20BEB7933Q36004259-93591074-EFE6-49AA-8832-12135B285FDEQ36305003-F0F513C8-E014-4DF4-B529-48CEC6C49250Q36956324-18CCAD50-85E0-4FF6-BB28-5F53C7003547
P2860
Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Standardized peptidome profili ...... e-of-flight mass spectrometry.
@ast
Standardized peptidome profili ...... e-of-flight mass spectrometry.
@en
type
label
Standardized peptidome profili ...... e-of-flight mass spectrometry.
@ast
Standardized peptidome profili ...... e-of-flight mass spectrometry.
@en
prefLabel
Standardized peptidome profili ...... e-of-flight mass spectrometry.
@ast
Standardized peptidome profili ...... e-of-flight mass spectrometry.
@en
P50
P1433
P1476
Standardized peptidome profili ...... e-of-flight mass spectrometry.
@en
P2093
Anke Oltmann
Julia Kase
P304
P356
10.1373/CLINCHEM.2006.077834
P407
P577
2007-02-01T00:00:00Z